The pharmacological effects and safety of the raw and prepared folium of Epimedium brevicornu Maxim. on improving kidney-yang deficiency syndrome and sexual dysfunction

Background: Kidney-Yang deficiency syndrome (KDS) is a group of diseases related to hypothalamic-pituitary-adrenal (HPA) axis and sexual dysfunction. The folium of Epimedium brevicornu Maxim. (FEB) includes raw and prepared slices, named RFEB and PFEB, respectively. PFEB is traditionally believed to...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Wang (Author), Juntao Li (Author), Xinyu Zheng (Author), Jian Xu (Author), Zhe Wang (Author), Senjie Li (Author), Qiang Yang (Author), Yue Wu (Author), Dong-Hua Yang (Author), Shen Yao (Author), Xiangwei Zheng (Author)
Format: Book
Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5e72812c18ef4268a9e8b46cebf1b51c
042 |a dc 
100 1 0 |a Kai Wang  |e author 
700 1 0 |a Juntao Li  |e author 
700 1 0 |a Xinyu Zheng  |e author 
700 1 0 |a Jian Xu  |e author 
700 1 0 |a Zhe Wang  |e author 
700 1 0 |a Senjie Li  |e author 
700 1 0 |a Qiang Yang  |e author 
700 1 0 |a Yue Wu  |e author 
700 1 0 |a Dong-Hua Yang  |e author 
700 1 0 |a Shen Yao  |e author 
700 1 0 |a Xiangwei Zheng  |e author 
245 0 0 |a The pharmacological effects and safety of the raw and prepared folium of Epimedium brevicornu Maxim. on improving kidney-yang deficiency syndrome and sexual dysfunction 
260 |b Frontiers Media S.A.,   |c 2023-07-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1233468 
520 |a Background: Kidney-Yang deficiency syndrome (KDS) is a group of diseases related to hypothalamic-pituitary-adrenal (HPA) axis and sexual dysfunction. The folium of Epimedium brevicornu Maxim. (FEB) includes raw and prepared slices, named RFEB and PFEB, respectively. PFEB is traditionally believed to be good for tonifying kidney-Yang and improving sexual dysfunction. However, there are few studies comparing the pharmacological effects of RFEB and PFEB, and their underlying mechanisms. In this study, we aimed to compare the effects and safety of RFEB and PFEB on the HPA axis and sexual function. Additionally, the mechanisms of their roles in relation to the neuroendocrine-immune (NEI) network in the KDS model mice were explored.Methods: Male adult C57BL/6 mice were treated with corticosterone to establish a KDS mouse model, and RFEB and PFEB were administered intragastrically. Corticotropin releasing hormone (CRH), adrenocorticotropic hormone (ACTH), cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), testosterone levels and oxidative damage indexes were measured. The mRNA and protein levels of CRH and ACTH in hypothalamus and pituitary, endothelial nitric oxide synthase (eNOS) and phosphodiesterase 5 (PDE5) in corpus cavernosum were examined. TNFα, IL-6, NF-κB, eNOS and PDE5 were investigated in mouse corpus cavernosum.Results: Our results showed that PFEB was more effective than RFEB in increasing corticosterone-suppressed ACTH levels, enhancing CRH levels and cAMP/cGMP ratio, and reducing oxidative damage. In vivo, PFEB significantly increased eNOS and inhibited PDE5 expression in corpus cavernosum. PFEB showed stronger protective effect on normal spleen lymphocytes from apoptosis both in vitro and in vivo. Additionally, it noticeably inhibited the levels of inflammatory cytokines in corpus cavernosum. Both RFEB and PFEB were safe and did not cause any clinical signs of toxicity in mice at the dosage of 20 times dosages of that in the Chinese Pharmacopeia.Conclusion: We demonstrated that PFEB was better than RFEB at tonifying the kidney-Yang by comparing their effects on improving the NEI network, which includes the HPA axis, immune system and corpus cavernosum. This study revealed that PFEB could significantly improve the sexual function of KDS mice by regulating the HPA axis and activating the immune system through the NEI network. 
546 |a EN 
690 |a processed folium of Epimedium brevicornu Maxim 
690 |a raw folium of Epimedium brevicornu Maxim 
690 |a hypothalamus-pituitary-adrenal axis 
690 |a sexual dysfunction 
690 |a neuroendocrine-immune network 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1233468/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/5e72812c18ef4268a9e8b46cebf1b51c  |z Connect to this object online.